The global prostate cancer diagnosis and treatment market was valued at USD 10.1 billion in 2019 and is expected to reach USD 13.2 billion by 2027, at a CAGR of 3.8% during the forecast period. Prostate cancer is one of the most common cancers among men, with an estimated 1 in 7 men diagnosed in their lifetime. In the United States, prostate cancer is the second most common cancer in men, with an estimated 174,650 new cases and 31,620 deaths in 2020. The early detection and treatment of prostate cancer are critical to improving survival rates and quality of life for patients.
The key players covered in this study
1.1 Prostate Cancer
Prostate cancer is a form of cancer that affects the prostate, a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. The American Cancer Society’s most recent estimates for prostate cancer in the United States are for 2017. In that year, there will be about 161,360 new cases of prostate cancer and about 26,730 deaths from prostate cancer. Prostate cancer is the third leading cause of death from cancer in men in the US, after lung cancer and colorectal cancer. Prostate cancer can occur at any age, but it is most common in older men. About 6 cases in 10 are diagnosed in men aged 65 or over, and it is rare before age 40.
The exact cause of prostate cancer is unknown, but research has identified certain risk factors. Age is the biggest risk factor for prostate cancer. The chance of having prostate cancer rises rapidly after age 50. About 6 out of 10 cases are diagnosed in men aged 65 or over. Other risk factors include family history and race/ethnicity. Having a father or brother with prostate cancer more than doubles a man’s risk of developing this disease himself. African American men have the highest risk of developing prostate cancer and are more than twice as likely to die from it as Caucasian men. Asian American and Hispanic/Latino men have a lower risk of developing and dying from prostate cancer than Caucasian men.
United States Prostate Cancer Diagnosis and Treatment Market Size and Forecast
1.1 United States Prostate Cancer Diagnosis and Treatment Market Size
Advancements in technology, rising awareness about early detection, and increasing government initiatives are the major factors driving the growth of this market. However, the high cost of treatment and lack of skilled personnel are restraining market growth to a certain extent.
The following are the major segments covered in this report:
* By Diagnosis Type:
* PSA Tests
* Imaging Techniques
* By Treatment Type:
* Localized Prostatectomy
* Radical Prostatectomy
* Robotic Assisted Radical Prostatectomy (RARP)
* Laparoscopic Radical Prostatectomy (LRP)
* Transurethral Resection of the Prostate (TURP)
* Focal Therapy
* Cryotherapy / Cryoablation
* High Intensity Focused Ultrasound (HIFU)
* Low Dose Rate Brachytherapy(LDRB)
Table of Content:
- Market Definition and Overview
- Research Method and Logic
- Market Competition Analysis
- Product and Service Analysis
- Strategies for Companies to Deal with the Impact of COVID-19
- Market Segment by Type, Historical Data, and Market Forecasts
- Market Segment by Application, Historical Data, and Market Forecasts
- Market by Region, Historical Data, and Market Forecasts
- Market Dynamic Analysis and Development Suggestions
Reportsandmarkets.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on Global industries, organizations, products, and trends.
Manager – Partner Relations & International Marketing
Ph: +1-352-353-0818 (US)